Perihospitalization hemoglobin-epoetin associations in U.S. hemodialysis patients, 1998 to 2003
- PMID: 17922742
- DOI: 10.1111/j.1542-4758.2007.00215.x
Perihospitalization hemoglobin-epoetin associations in U.S. hemodialysis patients, 1998 to 2003
Abstract
While hospitalization is common for hemodialysis patients, perihospitalization associations between hemoglobin levels and epoetin doses are not well characterized. U.S. Medicare claims were used to identify 71,360 hemodialysis patients hospitalized from 1998 to 2003. Hemoglobin levels, epoetin doses, and epoetin responsiveness index (ERI) were compared by calendar year. In the prehospitalization month, the mean hemoglobin levels increased from 10.96 g/dL in 1998 to 11.76 in 2003 and the mean epoetin doses from 63,715 to 75,012 U; corresponding values in the hospitalization month were 10.53 and 11.19 g/dL, and 66,623 and 80,569 U. In each year, prehospitalization hemoglobin levels were achieved within 2 months, but ERI declined to prehospitalization levels within 12 months only in 2000. With mixed models, hemoglobin declines in the 3 prehospitalization months grew between 1998 (-0.1362 g/dL/month) and 2003 (-0.2003 g/dL/month). Epoetin responsiveness index slopes were J-shaped, with values of 287.9, 221.1, and 356.5U/month per g/dL in 1998, 2000, and 2003. In the 3 postadmission months, a modest increase in the rapidity of hemoglobin recovery was seen (+0.2538 g/dL/month in 1998, +0.2743 in 2003), with increasing rates of ERI change (+8.7 U/month/g/dL in 1998, +146.8 in 2003). While time to recovery of prehospitalization hemoglobin levels remained constant year to year, epoetin doses and ERI did not, suggesting that optimum perihospitalization anemia management practices have yet to be determined.
Similar articles
-
Epoetin alfa use in patients with ESRD: an analysis of recent US prescribing patterns and hemoglobin outcomes.Am J Kidney Dis. 2005 Sep;46(3):481-8. doi: 10.1053/j.ajkd.2005.05.018. Am J Kidney Dis. 2005. PMID: 16129210
-
Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization.Am J Kidney Dis. 2009 Sep;54(3):498-510. doi: 10.1053/j.ajkd.2009.05.007. Epub 2009 Jul 23. Am J Kidney Dis. 2009. PMID: 19628315
-
Efficacy and safety of once-weekly intravenous epoetin alfa in maintaining hemoglobin levels in hemodialysis patients.J Nephrol. 2008 May-Jun;21(3):412-20. J Nephrol. 2008. PMID: 18587731 Clinical Trial.
-
[Hemoglobin variability in patients with chronic renal insuffiency].Nephrol Ther. 2008 Dec;4(7):549-52. doi: 10.1016/j.nephro.2008.04.010. Epub 2008 Nov 11. Nephrol Ther. 2008. PMID: 19004677 Review. French.
-
Managing the anemia of end-stage renal disease after hospitalization.Nephrol Nurs J. 2004 Sep-Oct;31(5):541-4. Nephrol Nurs J. 2004. PMID: 15518256 Review.
Cited by
-
Contemporary Practice of Anemia Treatment Among Dialysis Patients in the United States.Kidney Int Rep. 2023 Sep 7;8(12):2616-2624. doi: 10.1016/j.ekir.2023.09.009. eCollection 2023 Dec. Kidney Int Rep. 2023. PMID: 38106574 Free PMC article.
-
Haemoglobin variability and all-cause mortality in haemodialysis patients: A systematic review and meta-analysis.Nephrology (Carlton). 2019 Dec;24(12):1265-1272. doi: 10.1111/nep.13560. Epub 2019 Feb 28. Nephrology (Carlton). 2019. PMID: 30644618 Free PMC article.
-
Treatment of anemia in difficult-to-manage patients with chronic kidney disease.Kidney Int Suppl (2011). 2021 Apr;11(1):26-34. doi: 10.1016/j.kisu.2020.12.006. Epub 2021 Mar 18. Kidney Int Suppl (2011). 2021. PMID: 33777493 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical